Autism clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for

  • CM-AT for the Treatment of Children With Autism

    Sorry, in progress, not accepting new patients

    This is a Phase III, open label extension study evaluating the continued safety and efficacy of CM-AT in pediatric patients with autism with all levels of fecal chymotrypsin.

    San Francisco, California and other locations

Our lead scientists for Autism research studies include .

Last updated: